NCT07227389

Brief Summary

The goal of this study is to determine if a relationship can be detected between the administration of an opioid and quantitative respiratory depression in spontaneously breathing non-intubated patients who have undergone general anesthesia and have received perioperative opioids. The primary aim is to determine the temporal effect of opioid administration on respiratory depression as assessed by minute ventilation with a reduction of at least 20% in the percent of predicted minute ventilation. A secondary aim is to determine a dose response of opioid administration and its effect on minute ventilation. The investigators aim to determine the influence of opioid administration on minute ventilation on spontaneously breathing patients during post-anesthesia care unit (PACU) stay.

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
52

participants targeted

Target at P25-P50 for all trials

Timeline
33mo left

Started Dec 2025

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress14%
Dec 2025Jan 2029

First Submitted

Initial submission to the registry

November 7, 2025

Completed
5 days until next milestone

First Posted

Study publicly available on registry

November 12, 2025

Completed
19 days until next milestone

Study Start

First participant enrolled

December 1, 2025

Completed
3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2028

Expected
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2029

Last Updated

November 14, 2025

Status Verified

November 1, 2025

Enrollment Period

3 years

First QC Date

November 7, 2025

Last Update Submit

November 13, 2025

Conditions

Keywords

opioidsbio-impedancehypoxiahypercapniaminute ventilation

Outcome Measures

Primary Outcomes (4)

  • Respiratory interventions 1

    Initiation or cessation of mechanical ventilation

    Within 4 hours of patient admittance to Post Anesthetic Care Unit (PACU)

  • Respiratory interventions 2

    Initiation or cessation of Bilevel Positive Airway Pressure

    Within 4 hours of patient admittance to Post Anesthetic Care Unit

  • Respiratory interventions 3

    Initiation/cessation of high flow nasal cannula

    Within 4 hours of patient admittance to Post Anesthetic Care Unit

  • Respiratory interventions 4

    Initiation/cessation of low flow nasal cannula

    Within 4 hours of patient admittance to Post Anesthetic Care Unit

Secondary Outcomes (7)

  • Oxygen saturation of peripheral blood (SpO2)

    Duration of PACU stay (up to 4 hours)

  • Arterial Blood gas levels

    Duration of surgery (up to 2hrs)

  • Venous Blood gas levels

    Duration of surgery (up to 2hrs)

  • Hypercapnia

    Duration of patient stay in PACU (up to 4 hours)

  • Hypoxia

    Duration of patient stay in PACU (up to 4 hours)

  • +2 more secondary outcomes

Study Arms (1)

Study group

Patients receiving general anesthesia with an expected anesthetic time of at least 2 hours

Diagnostic Test: Respiratory volume monitoring

Interventions

Noninvasive continuous respiratory monitoring utilizing bio-impedance to detect tidal volumes, respiratory rate, and minute ventilation.

Study group

Eligibility Criteria

Age18 Years - 85 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Surgical patients receiving general anesthesia with an expected anesthetic time of at least 2 hours

You may qualify if:

  • Written informed consent
  • Adults ≥18 years of age and ≤85 years of age
  • Patients planned for general anesthesia with an expected anesthetic time of at least 2 hours
  • Patients expected to receive postoperative opioid analgesia

You may not qualify if:

  • Non-operative procedure (imaging)
  • Patients not admitted to the PACU postoperatively
  • Use of patient-controlled analgesia systems
  • Female patients who are pregnant or breastfeeding
  • Patients with asymmetric lung disease
  • American Society of Anesthesiologists (ASA) classification V
  • Emergency surgery (ASA E Modifier)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Detroit Medical Center

Mount Clemens, Michigan, 48043, United States

Location

MeSH Terms

Conditions

HypoxiaHypercapnia

Condition Hierarchy (Ancestors)

Signs and Symptoms, RespiratorySigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Wael Saasouh, MD

    Wayne State University

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Target Duration
1 Day
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Clinical Assistant Professor

Study Record Dates

First Submitted

November 7, 2025

First Posted

November 12, 2025

Study Start

December 1, 2025

Primary Completion (Estimated)

December 1, 2028

Study Completion (Estimated)

January 1, 2029

Last Updated

November 14, 2025

Record last verified: 2025-11

Data Sharing

IPD Sharing
Will not share

Locations